Trial Profile
ß-amyloid Imaging With BAY 94-9172 Positron Emission Tomography for Early Detection of Alzheimer's Disease in Patients With Mild Cognitive Impairment
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Jul 2019
Price :
$35
*
At a glance
- Drugs Florbetaben F18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors Life Molecular Imaging
- 21 May 2014 New trial record